Anti-inflamatório dexametasona: estudos de biodegradabilidade, toxicidade, ocorrência e degradação oxidativa avançada em efluente hospitalar

Detalhes bibliográficos
Ano de defesa: 2010
Autor(a) principal: Arsand, Daniel Ricardo lattes
Orientador(a): Martins, Ayrton Figueiredo lattes
Banca de defesa: Machado, ênio Leandro lattes, Silveira, Djalma Dias da lattes, Stülp, Simone lattes
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Santa Maria
Programa de Pós-Graduação: Programa de Pós-Graduação em Química
Departamento: Química
País: BR
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://repositorio.ufsm.br/handle/1/4202
Resumo: The presence of drugs and active substances in the environment has been a concern in recent years. A range of these compounds have been found in water treated in sewage treatment effluents, surface waters and less frequently in groundwater worldwide. The dexamethasone (DEX), an anti-inflammatory similar to hydrocortisone, is the most potent anti-inflammatory from the glucocorticosteroids, both being used in human and veterinary medicine. However, its use is related to problems of various orders. Considering the values PEC (Predicted Environmental Concentration) calculated for the concentration of DEX in the hospital effluents PA-HUSM, it can be said that they exceed the tolerable limit value (OECD) for the emission of effluents to aquatic environments (10 ng L-1), requiring additional study of environmental risk assessment. The amounts of DEX administered in PA-HUSM in Uni-Klinikum Freiburg (Germany, section tumors treatment) and the total amount of DEX administered in Germany (for the year 2007) was compared. Studies of biodegradation of DEX base, DEX acetate and DEX phosphate were conducted in accordance with standard methodology for OECD: Closed Bottle Test (CBT), Manometric Respirometry Test (MRT) and Zahn-Wellens Test (ZWT). Luminescent bacteria (Vibrio fischeri) were used in toxicological tests for evaluation of the toxicity of the aqueous solutions of the three chemical forms of DEX (base, acetate and phosphate), of the solutions post-biodegradation tests and after treatment solutions by electrocoagulation (EC) and/or photocatalysis (FC). It was used advanced oxidation processes (EC and FC) to study the chemical degradation and/or adsorptive removal of DEX from aqueous solutions and samples of hospital sewage. The combination of EC and FC processes in the removal of DEX was also investigated. The optimization of experiments was done with factorial design with the aid of response surface methodology (RSM). To study the degradation of the organic load was developed a new methodology for the determination of COD in the effluent hospital using deconvolution technique applied to UV-spectrophotometry. Likewise, it has developed procedures for clean up and pre-concentration of DEX with the aid of solid phase extraction (SPE). Studies of ready-degradation and biodegradation in aqueous solution showed that the chemical forms of the studied anti-inflammatory DEX are not biodegradable in the environment. Under optimized conditions, the EC presented capacity to remove about 30% of DEX, both, in aqueous solution and in samples of hospital sewage, and the adsorption process showed the predominant removal effect of DEX. According to the factorial design (RSM) the applied current and the concentration of supporting electrolyte were the most significant factors in the process. In studies of photocatalytic degradation in aqueous solution followed by chromatographic determination (HPLC-DAD) occurs total disappearance of the DEX signal in the first minutes (4-5 min) of photocatalysis. However, taking the reduction of COD measured by nondispersive IR as a parameter for mineralization, it appears that there was only partial mineralization; DEX was degraded to photoproducts that do not absorb in the spectral range used (UV). Toxicological studies with the luminescent bacteria Vibrio fischeri showed that the chemical forms of DEX (base, acetate and phosphate) have no acute or chronic toxicity, as well as products of biodegradation, photodegradation or electrocoagulation. Despite the fact that DEX not presented acute or chronic toxicity, it is not biodegradable, and therefore must undergo removal from the hospital sewage before being released to the aquatic environment.
id UFSM_612529ca62beaba4a9a5df1dae28945c
oai_identifier_str oai:repositorio.ufsm.br:1/4202
network_acronym_str UFSM
network_name_str Biblioteca Digital de Teses e Dissertações do UFSM
repository_id_str
spelling 2017-05-122017-05-122010-12-15ARSAND, Daniel Ricardo. Anti-inflammatory dexamethasone: studies of biodegradability, toxicity, occurrence and advanced oxidative degradation in hospital effluent. 2010. 146 f. Tese (Doutorado em Química) - Universidade Federal de Santa Maria, Santa Maria, 2010.http://repositorio.ufsm.br/handle/1/4202The presence of drugs and active substances in the environment has been a concern in recent years. A range of these compounds have been found in water treated in sewage treatment effluents, surface waters and less frequently in groundwater worldwide. The dexamethasone (DEX), an anti-inflammatory similar to hydrocortisone, is the most potent anti-inflammatory from the glucocorticosteroids, both being used in human and veterinary medicine. However, its use is related to problems of various orders. Considering the values PEC (Predicted Environmental Concentration) calculated for the concentration of DEX in the hospital effluents PA-HUSM, it can be said that they exceed the tolerable limit value (OECD) for the emission of effluents to aquatic environments (10 ng L-1), requiring additional study of environmental risk assessment. The amounts of DEX administered in PA-HUSM in Uni-Klinikum Freiburg (Germany, section tumors treatment) and the total amount of DEX administered in Germany (for the year 2007) was compared. Studies of biodegradation of DEX base, DEX acetate and DEX phosphate were conducted in accordance with standard methodology for OECD: Closed Bottle Test (CBT), Manometric Respirometry Test (MRT) and Zahn-Wellens Test (ZWT). Luminescent bacteria (Vibrio fischeri) were used in toxicological tests for evaluation of the toxicity of the aqueous solutions of the three chemical forms of DEX (base, acetate and phosphate), of the solutions post-biodegradation tests and after treatment solutions by electrocoagulation (EC) and/or photocatalysis (FC). It was used advanced oxidation processes (EC and FC) to study the chemical degradation and/or adsorptive removal of DEX from aqueous solutions and samples of hospital sewage. The combination of EC and FC processes in the removal of DEX was also investigated. The optimization of experiments was done with factorial design with the aid of response surface methodology (RSM). To study the degradation of the organic load was developed a new methodology for the determination of COD in the effluent hospital using deconvolution technique applied to UV-spectrophotometry. Likewise, it has developed procedures for clean up and pre-concentration of DEX with the aid of solid phase extraction (SPE). Studies of ready-degradation and biodegradation in aqueous solution showed that the chemical forms of the studied anti-inflammatory DEX are not biodegradable in the environment. Under optimized conditions, the EC presented capacity to remove about 30% of DEX, both, in aqueous solution and in samples of hospital sewage, and the adsorption process showed the predominant removal effect of DEX. According to the factorial design (RSM) the applied current and the concentration of supporting electrolyte were the most significant factors in the process. In studies of photocatalytic degradation in aqueous solution followed by chromatographic determination (HPLC-DAD) occurs total disappearance of the DEX signal in the first minutes (4-5 min) of photocatalysis. However, taking the reduction of COD measured by nondispersive IR as a parameter for mineralization, it appears that there was only partial mineralization; DEX was degraded to photoproducts that do not absorb in the spectral range used (UV). Toxicological studies with the luminescent bacteria Vibrio fischeri showed that the chemical forms of DEX (base, acetate and phosphate) have no acute or chronic toxicity, as well as products of biodegradation, photodegradation or electrocoagulation. Despite the fact that DEX not presented acute or chronic toxicity, it is not biodegradable, and therefore must undergo removal from the hospital sewage before being released to the aquatic environment.A presença de fármacos e substâncias ativas no ambiente vem sendo causa de preocupação nos últimos anos. Uma gama destes compostos tem sido encontrada em águas tratadas em estações de tratamento de efluentes, águas superficiais e, menos frequentemente, em águas subterrâneas, em todo o mundo. A Dexametasona (DEX), um anti-inflamatório análogo à hidrocortisona, é o mais potente anti-inflamatório dentre os glucocorticoesteróides, sendo usado tanto na medicina humana quanto na medicina veterinária. Entretanto, seu uso está relacionado a problemas de diversas ordens. Considerando-se os valores PEC (Predicted Environmental Concentration) calculados para a concentração de DEX no efluente hospitalar do HUSM, pode-se afirmar que estes excedem o valor limite tolerável (OECD) para a emissão de efluentes para ambientes aquáticos (10 ng L-1), sendo necessário estudo complementar de avaliação do risco ambiental. Foram comparadas as quantidades de DEX administradas no PA-HUSM, na Uni-Klinikum Freiburg (Alemanha, setor de tratamentos de tumores) e as quantidade de DEX administradas na Alemanha em sua totalidade (referentes ao ano 2007). Estudos de biodegradação de DEX base, acetato de DEX e fosfato de DEX foram conduzidos de acordo com metodologia padrão para a OECD: Closed Bottle Teste (CBT), Manometric Respirometry Test (MRT) e Zahn-Wellens Test (ZWT). Bactérias luminescentes (Vibrio fischeri) foram utilizadas nos testes ecotoxicológicos, avaliando-se as toxicidades de soluções aquosas das três formas químicas de DEX (base, acetato e fosfato), das soluções pós-testes de biodegradação e de soluções pós-tratamento por eletrocoagulação (EC) e/ou fotocatálise (FC). Foram usados processos avançados de oxidação (EC e FC) para estudar a degradação química e/ou remoção adsortiva de DEX de soluções aquosas e de amostras de efluente hospitalar. Também investigou-se a combinação dos processos EC e FC na remoção de DEX. Utilizou-se planejamento fatorial com metodologia de superfície de resposta (RSM) para a otimização dos experimentos. Para o estudo da degradação da carga orgânica foi desenvolvida metodologia inédita para a determinação da DQO no efluente hospitalar usando-se técnica de deconvolução UV-espectrofotométrica. Da mesma forma, desenvolveu-se procedimento de clean up e pré-concentração de DEX com auxílio de extração em fase sólida (SPE). Os estudos de pronta-degradação e biodegradação, em solução aquosa, demonstraram que as formas químicas estudadas do anti-inflamatório DEX não são biodegradáveis no ambiente. Nas condições otimizadas, a EC apresentou capacidade de remoção de cerca de 30% de DEX, tanto em solução aquosa como em amostra de efluente hospitalar, sendo que a adsorção se mostrou o processo predominante de remoção de DEX. A corrente aplicada e a concentração de eletrólito suporte foram os fatores mais significativos no processo, segundo o planejamento fatorial (RSM). Nos estudos de degradação fotocatalítica em solução aquosa, acompanhados por meio de determinação cromatográfica (HPLC-DAD), ocorre desaparecimento total do sinal referente à DEX já nos primeiros instantes (4-5 minutos) de fotocatálise. Entretanto, tomando-se a redução de COD medida por EIV não dispersivo como parâmetro para mineralização, verifica-se que houve apenas mineralização parcial, tendo sido a DEX degradada a fotoprodutos que não absorvem na faixa espectral utilizada (UV). Os estudos toxicológicos com bactérias luminescentes Vibrio fischeri demonstraram que as formas químicas de DEX (base, acetato e fosfato) não apresentam toxicidade aguda ou crônica, bem como os produtos de biodegradação, eletrocoagulação ou fotodegradação. Apesar da DEX não apresentar toxicidade aguda ou crônica, não é biodegradável, e deve, portanto, sofrer remoção do efluente hospitalar antes de ser lançada ao ambiente aquático.Coordenação de Aperfeiçoamento de Pessoal de Nível Superiorapplication/pdfporUniversidade Federal de Santa MariaPrograma de Pós-Graduação em QuímicaUFSMBRQuímicaDexametasonaProcessos de biodegradaçãoToxicidadeDexamethasoneBiodegradation processesToxicityCNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICAAnti-inflamatório dexametasona: estudos de biodegradabilidade, toxicidade, ocorrência e degradação oxidativa avançada em efluente hospitalarAnti-inflammatory dexamethasone: studies of biodegradability, toxicity, occurrence and advanced oxidative degradation in hospital effluentinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisMartins, Ayrton Figueiredohttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4787438A0Machado, ênio Leandrohttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4784684U8Silveira, Djalma Dias dahttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4723875A1Stülp, Simonehttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4799529Y9http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4799860P2Arsand, Daniel Ricardo100600000000400300300300500300ade6000d-a348-4d49-a531-6500a65a153a8c899616-6a94-42d0-8061-f7d767fa6a5583525661-81e2-4c1d-bbde-36daa91d8442350f856f-fa7d-44e9-9946-1d1e2ad582e23e2f3948-001f-4b11-8849-b04265a2288cinfo:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações do UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMORIGINALARSAND, DANIEL RICARDO.pdfapplication/pdf4050370http://repositorio.ufsm.br/bitstream/1/4202/1/ARSAND%2c%20DANIEL%20RICARDO.pdf4e89a6b5dcab9a905cd4696cd9041e8bMD51TEXTARSAND, DANIEL RICARDO.pdf.txtARSAND, DANIEL RICARDO.pdf.txtExtracted texttext/plain269682http://repositorio.ufsm.br/bitstream/1/4202/2/ARSAND%2c%20DANIEL%20RICARDO.pdf.txtb53794e51cc970f1de3b0fa032df18ffMD52THUMBNAILARSAND, DANIEL RICARDO.pdf.jpgARSAND, DANIEL RICARDO.pdf.jpgIM Thumbnailimage/jpeg5023http://repositorio.ufsm.br/bitstream/1/4202/3/ARSAND%2c%20DANIEL%20RICARDO.pdf.jpgb3a5279f89bd378db87fd7f3f8e11494MD531/42022017-07-25 11:05:11.163oai:repositorio.ufsm.br:1/4202Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2017-07-25T14:05:11Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.por.fl_str_mv Anti-inflamatório dexametasona: estudos de biodegradabilidade, toxicidade, ocorrência e degradação oxidativa avançada em efluente hospitalar
dc.title.alternative.eng.fl_str_mv Anti-inflammatory dexamethasone: studies of biodegradability, toxicity, occurrence and advanced oxidative degradation in hospital effluent
title Anti-inflamatório dexametasona: estudos de biodegradabilidade, toxicidade, ocorrência e degradação oxidativa avançada em efluente hospitalar
spellingShingle Anti-inflamatório dexametasona: estudos de biodegradabilidade, toxicidade, ocorrência e degradação oxidativa avançada em efluente hospitalar
Arsand, Daniel Ricardo
Dexametasona
Processos de biodegradação
Toxicidade
Dexamethasone
Biodegradation processes
Toxicity
CNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA
title_short Anti-inflamatório dexametasona: estudos de biodegradabilidade, toxicidade, ocorrência e degradação oxidativa avançada em efluente hospitalar
title_full Anti-inflamatório dexametasona: estudos de biodegradabilidade, toxicidade, ocorrência e degradação oxidativa avançada em efluente hospitalar
title_fullStr Anti-inflamatório dexametasona: estudos de biodegradabilidade, toxicidade, ocorrência e degradação oxidativa avançada em efluente hospitalar
title_full_unstemmed Anti-inflamatório dexametasona: estudos de biodegradabilidade, toxicidade, ocorrência e degradação oxidativa avançada em efluente hospitalar
title_sort Anti-inflamatório dexametasona: estudos de biodegradabilidade, toxicidade, ocorrência e degradação oxidativa avançada em efluente hospitalar
author Arsand, Daniel Ricardo
author_facet Arsand, Daniel Ricardo
author_role author
dc.contributor.advisor1.fl_str_mv Martins, Ayrton Figueiredo
dc.contributor.advisor1Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4787438A0
dc.contributor.referee1.fl_str_mv Machado, ênio Leandro
dc.contributor.referee1Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4784684U8
dc.contributor.referee2.fl_str_mv Silveira, Djalma Dias da
dc.contributor.referee2Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4723875A1
dc.contributor.referee3.fl_str_mv Stülp, Simone
dc.contributor.referee3Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4799529Y9
dc.contributor.authorLattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4799860P2
dc.contributor.author.fl_str_mv Arsand, Daniel Ricardo
contributor_str_mv Martins, Ayrton Figueiredo
Machado, ênio Leandro
Silveira, Djalma Dias da
Stülp, Simone
dc.subject.por.fl_str_mv Dexametasona
Processos de biodegradação
Toxicidade
topic Dexametasona
Processos de biodegradação
Toxicidade
Dexamethasone
Biodegradation processes
Toxicity
CNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA
dc.subject.eng.fl_str_mv Dexamethasone
Biodegradation processes
Toxicity
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA
description The presence of drugs and active substances in the environment has been a concern in recent years. A range of these compounds have been found in water treated in sewage treatment effluents, surface waters and less frequently in groundwater worldwide. The dexamethasone (DEX), an anti-inflammatory similar to hydrocortisone, is the most potent anti-inflammatory from the glucocorticosteroids, both being used in human and veterinary medicine. However, its use is related to problems of various orders. Considering the values PEC (Predicted Environmental Concentration) calculated for the concentration of DEX in the hospital effluents PA-HUSM, it can be said that they exceed the tolerable limit value (OECD) for the emission of effluents to aquatic environments (10 ng L-1), requiring additional study of environmental risk assessment. The amounts of DEX administered in PA-HUSM in Uni-Klinikum Freiburg (Germany, section tumors treatment) and the total amount of DEX administered in Germany (for the year 2007) was compared. Studies of biodegradation of DEX base, DEX acetate and DEX phosphate were conducted in accordance with standard methodology for OECD: Closed Bottle Test (CBT), Manometric Respirometry Test (MRT) and Zahn-Wellens Test (ZWT). Luminescent bacteria (Vibrio fischeri) were used in toxicological tests for evaluation of the toxicity of the aqueous solutions of the three chemical forms of DEX (base, acetate and phosphate), of the solutions post-biodegradation tests and after treatment solutions by electrocoagulation (EC) and/or photocatalysis (FC). It was used advanced oxidation processes (EC and FC) to study the chemical degradation and/or adsorptive removal of DEX from aqueous solutions and samples of hospital sewage. The combination of EC and FC processes in the removal of DEX was also investigated. The optimization of experiments was done with factorial design with the aid of response surface methodology (RSM). To study the degradation of the organic load was developed a new methodology for the determination of COD in the effluent hospital using deconvolution technique applied to UV-spectrophotometry. Likewise, it has developed procedures for clean up and pre-concentration of DEX with the aid of solid phase extraction (SPE). Studies of ready-degradation and biodegradation in aqueous solution showed that the chemical forms of the studied anti-inflammatory DEX are not biodegradable in the environment. Under optimized conditions, the EC presented capacity to remove about 30% of DEX, both, in aqueous solution and in samples of hospital sewage, and the adsorption process showed the predominant removal effect of DEX. According to the factorial design (RSM) the applied current and the concentration of supporting electrolyte were the most significant factors in the process. In studies of photocatalytic degradation in aqueous solution followed by chromatographic determination (HPLC-DAD) occurs total disappearance of the DEX signal in the first minutes (4-5 min) of photocatalysis. However, taking the reduction of COD measured by nondispersive IR as a parameter for mineralization, it appears that there was only partial mineralization; DEX was degraded to photoproducts that do not absorb in the spectral range used (UV). Toxicological studies with the luminescent bacteria Vibrio fischeri showed that the chemical forms of DEX (base, acetate and phosphate) have no acute or chronic toxicity, as well as products of biodegradation, photodegradation or electrocoagulation. Despite the fact that DEX not presented acute or chronic toxicity, it is not biodegradable, and therefore must undergo removal from the hospital sewage before being released to the aquatic environment.
publishDate 2010
dc.date.issued.fl_str_mv 2010-12-15
dc.date.accessioned.fl_str_mv 2017-05-12
dc.date.available.fl_str_mv 2017-05-12
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv ARSAND, Daniel Ricardo. Anti-inflammatory dexamethasone: studies of biodegradability, toxicity, occurrence and advanced oxidative degradation in hospital effluent. 2010. 146 f. Tese (Doutorado em Química) - Universidade Federal de Santa Maria, Santa Maria, 2010.
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/4202
identifier_str_mv ARSAND, Daniel Ricardo. Anti-inflammatory dexamethasone: studies of biodegradability, toxicity, occurrence and advanced oxidative degradation in hospital effluent. 2010. 146 f. Tese (Doutorado em Química) - Universidade Federal de Santa Maria, Santa Maria, 2010.
url http://repositorio.ufsm.br/handle/1/4202
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 100600000000
dc.relation.confidence.fl_str_mv 400
300
300
300
500
300
dc.relation.authority.fl_str_mv ade6000d-a348-4d49-a531-6500a65a153a
8c899616-6a94-42d0-8061-f7d767fa6a55
83525661-81e2-4c1d-bbde-36daa91d8442
350f856f-fa7d-44e9-9946-1d1e2ad582e2
3e2f3948-001f-4b11-8849-b04265a2288c
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Química
dc.publisher.initials.fl_str_mv UFSM
dc.publisher.country.fl_str_mv BR
dc.publisher.department.fl_str_mv Química
publisher.none.fl_str_mv Universidade Federal de Santa Maria
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações do UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Biblioteca Digital de Teses e Dissertações do UFSM
collection Biblioteca Digital de Teses e Dissertações do UFSM
bitstream.url.fl_str_mv http://repositorio.ufsm.br/bitstream/1/4202/1/ARSAND%2c%20DANIEL%20RICARDO.pdf
http://repositorio.ufsm.br/bitstream/1/4202/2/ARSAND%2c%20DANIEL%20RICARDO.pdf.txt
http://repositorio.ufsm.br/bitstream/1/4202/3/ARSAND%2c%20DANIEL%20RICARDO.pdf.jpg
bitstream.checksum.fl_str_mv 4e89a6b5dcab9a905cd4696cd9041e8b
b53794e51cc970f1de3b0fa032df18ff
b3a5279f89bd378db87fd7f3f8e11494
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1793240118522281984